Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.
about
Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.Methods for identifying 30 chronic conditions: application to administrative data.Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data.Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.Use of Population-based Data to Demonstrate How Waitlist-based Metrics Overestimate Geographic Disparities in Access to Liver Transplant CareRisk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionPrevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designContraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performanceValidation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative databaseChanges in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: data from a national US cohort.Association Between Cirrhosis and Stroke in a Nationally Representative Cohort.Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life.Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records.Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.Increased Distance to a Liver Transplant Center Is Associated With Higher Mortality for Patients With Chronic Liver Failure.Care delivery and outcomes among US veterans with hepatitis B: A national cohort study.Obesity is independently associated with infection in hospitalised patients with end-stage liver disease.Use of administrative medical databases in population-based research.Palliative care access for hospitalized patients with end-stage liver disease across the United States.Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
P2860
Q30366707-DF5DBF52-7123-447C-8755-919FDB443EEEQ30863587-6FC6C2D0-31ED-480B-9D86-607AC83D3FBFQ30935606-94C94461-B281-4718-B32D-04B49D059A13Q30993162-324115F8-804A-47EE-82F2-ABB6EF52CA61Q31028268-9E1BB6C3-FD67-40FE-9E09-399188068E25Q31072650-ECBE177D-2BA1-4C5B-B297-97CB0AB89BE4Q34670561-7B26793F-39E5-41F3-8DF2-CEADDB35756EQ34675189-4337452F-7E51-4FC6-9F4B-A75A33767CECQ35150425-151BA04D-31EA-4497-A28E-F7EFFFC1A3F2Q35836747-34F375B8-D771-4FD9-8C34-77F6F2CD968CQ36072747-93E09A01-0829-46C0-894D-30497421BFCAQ37112170-E3B12D00-DB5F-4FEE-826E-0B61D77CCEA5Q38057696-4B8F25EB-4567-49E1-BF02-E8CC13297A0AQ38403350-803ECBB0-5572-40AF-AB1B-A0AB83AB1FABQ38606004-9CA5DDDC-95F0-4494-8B75-81E4D0BF1070Q38740576-909D69D8-D183-4EBC-BB1B-DE475EE0280EQ38759689-C74123C2-1C6F-49FD-A183-7C4643E0C417Q38800510-C39BD533-445E-40B9-9804-78F84DF520D2Q39349699-C9D2D7A6-CA2D-4A20-922A-1287315C0A3EQ39458281-B6657DD7-D04C-4D29-858F-C5142E5052C5Q39635570-F7D31FF3-DF4D-4FB5-948B-24F3241FE706Q40314245-C34D06C5-6B15-4DC7-A753-35BBBE813E99Q40329784-E90222B6-8A0B-4B2E-AD61-D2A546F85DB3Q40933907-86E9891C-B316-4C62-977B-5F6E5B57BCDCQ44703807-51C5E401-FEAA-4C3C-AFCB-62A2835EFA71Q53077910-DE1B4B07-2ED2-4969-B7F7-E2E7E54256FEQ58723499-98A58383-05CF-4F65-9B4E-AEDE0723724F
P2860
Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Validation of three coding alg ...... in an administrative database.
@ast
Validation of three coding alg ...... in an administrative database.
@en
Validation of three coding alg ...... in an administrative database.
@nl
type
label
Validation of three coding alg ...... in an administrative database.
@ast
Validation of three coding alg ...... in an administrative database.
@en
Validation of three coding alg ...... in an administrative database.
@nl
prefLabel
Validation of three coding alg ...... in an administrative database.
@ast
Validation of three coding alg ...... in an administrative database.
@en
Validation of three coding alg ...... in an administrative database.
@nl
P2093
P2860
P356
P1476
Validation of three coding alg ...... in an administrative database.
@en
P2093
D Goldberg
Mark Weiner
Sd Halpern
Vincent Lo Re
P2860
P304
P356
10.1002/PDS.3290
P577
2012-06-04T00:00:00Z